Minimal residual disease monitoring by Ig/TCR gene rearrangements predicts post-transplant relapse and survival in adult patients with acute lymphoblastic leukemia

Ann Hematol. 2024 Nov;103(11):4831-4833. doi: 10.1007/s00277-024-05943-1. Epub 2024 Aug 21.

Michael Stephan Bader^{1

2}, Susanne Kubetzko³, Beat Werner Schäfer³, Christian Arranto^{1

2}, Beatrice Drexler^{1

2}, Jörg Halter^{1

2}, Jakob R Passweg^{1

2}, Michael Medinger^{4

5}

¹ Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.
² University of Basel, Basel, Switzerland.
³ Division of Oncology, University Children's Hospital, Zürich, Switzerland.
⁴ Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland. [email protected].
⁵ University of Basel, Basel, Switzerland. [email protected].

No abstract available

Publication types